Does ATORVASTATIN Cause Skin hypertrophy? 26 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Skin hypertrophy have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.
26
Reports of Skin hypertrophy with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
0
Deaths
11
Hospitalizations
How Dangerous Is Skin hypertrophy From ATORVASTATIN?
Of the 26 reports, 11 (42.3%) required hospitalization, and 8 (30.8%) were considered life-threatening.
Is Skin hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Skin hypertrophy?
DUPILUMAB (149)
SECUKINUMAB (134)
ADALIMUMAB (105)
ETANERCEPT (48)
METHOTREXATE (42)
RITUXIMAB (41)
TACROLIMUS (40)
OMALIZUMAB (35)
PREDNISOLONE (35)
SUNITINIB MALATE (32)
Which ATORVASTATIN Alternatives Have Lower Skin hypertrophy Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM